SEPTInvestingStart Free

KZIA 424B3: SEC filing

Kazia Therapeutics

Filed with the SEC on · accession 0001213900-26-101971

KZIA filed a 424B3 (prospectus (offering)) with the SEC on Sep 22, 2026. The final terms of an offering of shares or bonds. The stock moved +2.5% by the first close after the filing.

Summary of the filing

Kazia Therapeutics announced that its licensee Sovargen Co. dosed the first patient in a Phase 1b/2a trial of paxalisib for rare seizure disorders, triggering a $2 million milestone payment to Kazia.

For details, click here →How to read a 424B3 →

Key details

Milestone payment triggered by first patient dosed$2.0M
Potential additional development and regulatory milestones$17.0M
Licensor and filerKazia Therapeutics Limited
LicenseeSovargen Co., Ltd.
Chief executive officerJohn Friend
Ceo of sovargenCheolwon Park

How KZIA stock reacted

Close before

$10.65

Sep 21, 2026

First close after

+2.54%

$10.92

5 trading days

-9.86%

$9.60

Since filing

-32.58%

$7.18

✦ Ask GOAX AI about this filing — what it means for KZIA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for KZIA?

Click here

Frequently asked questions

What did KZIA file with the SEC on Sep 22, 2026?

KZIA filed a 424B3 (SEC filing). Kazia Therapeutics announced that its licensee Sovargen Co. dosed the first patient in a Phase 1b/2a trial of paxalisib for rare seizure disorders, triggering a $2 million milestone payment to Kazia.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did KZIA stock react to this filing?

KZIA closed at $10.65 before the filing and $10.92 on Sep 22, 2026 (+2.54%). Five trading days later: $9.60 (-9.86%).

Other KZIA SEC filings

Get alerts when KZIA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
KZIA overviewKZIA analysisKZIA newsLatest SEC filings